Galbraith Kenneth — SEC Form 4 filings
SEC reporting owner CIK 1567045. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-01-06 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 189,586 shares, $4,192,987 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 47,528 shares @ $27.02 ($1,284,311) in Zymeworks Inc., filed 2025-12-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Zymeworks Inc. (ZYME) | Chair & CEO, Director | 5 | — | 6 legs · 189,586 sh · $4,192,987 | 17 |
Form 4 filings — Galbraith Kenneth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-12 | 4 | Zymeworks Inc. (ZYME) | Option exercise (M): 64,000 @ $0 · Sale (S): 30,424 @ $22.67 · Option exercise (M): 64,000 (derivative) @ $0 · Grant/award (A): 216,000 (derivative) @ $0 · Grant/award (A): 144,000 (derivative) @ $0 · Grant/award (A): 222,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Zymeworks Inc. (ZYME) | Option exercise (M): 47,668 @ $0 · Sale (S): 22,657 @ $25.10 · Option exercise (M): 66,666 @ $0 · Sale (S): 31,686 @ $25.10 · Option exercise (M): 47,668 (derivative) @ $0 · Option exercise (M): 66,666 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Zymeworks Inc. (ZYME) | Option exercise (M): 100,000 @ $0 · Sale (S): 47,528 @ $27.02 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 288,000 (derivative) @ $0 · Grant/award (A): 192,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Zymeworks Inc. (ZYME) | Option exercise (M): 47,666 @ $0 · Sale (S): 23,885 @ $14.92 · Option exercise (M): 66,666 @ $0 · Sale (S): 33,406 @ $14.92 · Option exercise (M): 47,666 (derivative) @ $0 · Option exercise (M): 66,666 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1567045 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →